Outcomes in the treatment of aberrant subclavian arteries using the hybrid approach. (30th September 2022)

• Record Type: Journal Article
• Authors: Ben Ahmed, Sabrina; Settembre, Nicla; Touma, Joseph; Brouat, Anthony; Favre, Jean-Pierre; Jean Baptiste, Elixene; Chaufour, Xavier; Rosset, Eugenio
• Is Part Of: Interactive cardiovascular and thoracic surgery. Volume 35:Number 5(2022)
• Publication Date: 2022-09-30
• Subjects: Aberrant subclavian artery -- Kommerell's diverticulum -- Hybrid approach -- Surgical treatment -- Endovascular treatment -- ARDS -- Acute respiratory distress syndrome; Chest -- Surgery -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; 616.1
• DOI: 10.1093/icvts/ivac230
• Languages: English
• ISSNs: 1569-9293

Abstract

Abstract and keywords: OBJECTIVES: Aberrant subclavian artery (ASCA) occurs rarely but is one of the most frequent anatomical variations of the supra-aortic trunks. No consensus has been established on its best treatment. The goal of this study was to report the outcomes of ASCA treated by the hybrid approach. METHODS: This non-interventional retrospective multicentre analysis included patients treated for ASCA by the hybrid approach in 12 French university hospitals between 2007 and 2019. The hybrid approach was defined as an endovascular procedure combined with open surgery or a hybrid stent graft. Patients were divided in 4 groups (from less to more complex treatment). The primary end point was 30-day mortality. The secondary end points were 30-day complications and late mortality. RESULTS: This study included 43 patients. The mean age was 65 (SD, standard deviation: 16) years. Symptoms were found in 33 patients. Subclavian revascularization combined with aberrant subclavian artery occlusion was undertaken in 13 patients. Unilateral and bilateral subclavian revascularization combined with a thoracic aortic stent graft was undertaken in 11 and 6 patients, respectively. Total aortic arch repair combined with a thoracic aortic stent graft was undertaken in 13 patients. Thirty-day mortality was 2.3% with a technical success rate of 95.3%. The 30-day major postoperative complication rate was 16.3%: 4 strokes, 2 tamponades, 1 acute respiratory distress syndrome. Mean follow-up was 56.3 (SD: 44.7) months. The late mortality was 18.6%. CONCLUSIONS: The ASCA hybrid approach is feasible, safe and effective with low early mortality. Morbidity is rather high. However, it increases with the complexity of the hybrid approach, which should be kept as simple as possible if the anatomical morphology allows. Abstract : Aberrant subclavian artery (ASCA), also named "arteria lusoria", is the most frequent anatomical variation of the supra-aortic trunks (SAT).